PD-L1 expression in immune cells is a favorable prognostic factor for nasopharyngeal carcinoma.


Sahinli H., Akyürek N., Yılmaz M., Kandemir O., Duran A. O. , Kulaçoğlu S., ...More

Indian journal of cancer, vol.58, pp.561-566, 2021 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 58
  • Publication Date: 2021
  • Doi Number: 10.4103/ijc.ijc_459_19
  • Journal Name: Indian journal of cancer
  • Journal Indexes: Science Citation Index Expanded, Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, CINAHL, EMBASE, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.561-566
  • Keywords: Nasopharyngeal carcinoma, prognosis, programmed death ligand-1, TUMOR-INFILTRATING LYMPHOCYTES, PROGRAMMED DEATH LIGAND-1, GASTRIC-CANCER, DISTINCT EXPRESSION, T-CELLS, MICROENVIRONMENT, CHEMORADIOTHERAPY, RADIOTHERAPY, SURVIVAL, PHASE

Abstract

Background: Programmed death-ligand 1 (PD-L1) has been determined as a reliable prognostic factor for various malignancies. In this study, we aimed to determine the prognostic effect of PD-L1 expression in tumor-infiltrating immune cells (TIICs) of nasopharyngeal carcinoma (NPC) patients.